Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Angiogenesis
Published in: Angiogenesis 2/2004

01-06-2004

In vivo videomicroscopy reveals differential effects of the vascular-targeting agent ZD6126 and the anti-angiogenic agent ZD6474 on vascular function in a liver metastasis model

Authors: Hemanth Varghese, Lisa Mackenzie, Alan Groom, Christopher Ellis, Anderson Ryan, Ian Macdonald, Ann Chambers

Published in: Angiogenesis | Issue 2/2004

Login to get access
Metadata
Title
In vivo videomicroscopy reveals differential effects of the vascular-targeting agent ZD6126 and the anti-angiogenic agent ZD6474 on vascular function in a liver metastasis model
Authors
Hemanth Varghese
Lisa Mackenzie
Alan Groom
Christopher Ellis
Anderson Ryan
Ian Macdonald
Ann Chambers
Publication date
01-06-2004
Publisher
Kluwer Academic Publishers
Published in
Angiogenesis / Issue 2/2004
Print ISSN: 0969-6970
Electronic ISSN: 1573-7209
DOI
https://doi.org/10.1007/s10456-004-1941-3

Other articles of this Issue 2/2004

Angiogenesis 2/2004 Go to the issue

OriginalPaper

Protamine enhances uptake of cationic liposomes in angiogenic microvessels of solid tumours

OriginalPaper

Inhibition of FGF receptor activity in glioma implanted into the mouse brain using the tetracyclin-regulated expression system

OriginalPaper

Small molecule inhibitors of methionine aminopeptidase type 2 (MetAP-2) fail to inhibit endothelial cell proliferation or formation of microvessels from rat aortic rings in vitro

OriginalPaper

Abstracts of the 15th Endothelial Cell Research Symposium Maastricht Auditorium, Maastricht, The Netherlands 23 November 2004

OriginalPaper

Withaferin A is a potent inhibitor of angiogenesis

OriginalPaper

Tumor-derived prostaglandin E2 and transforming growth factor-β stimulate endothelial cell motility through inhibition of protein phosphatase-2A and involvement of PTEN and phosphatidy linositide 3-kinase
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits